A new antibacterial carrier of hyaluronic acid gel.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 17013739.
- Also identified by PMC identifier 2778615.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Postoperative infection following total joint arthroplasty is thought to be one of the most serious and devastating complications. To develop an effective treatment for this complication, we tested a bioabsorbable antibacterial carrier that is made from novel cross-linked hyaluronic acid (HA) gel and gentamicin (GM). Antibacterial activity of the carrier was evaluated by the agar diffusion test, direct contact test, in vivo mouse model, and in vivo rabbit osteomyelitis model. GM-containing HA gel suppressed bacterial growth both in vitro and in vivo. In the rabbit osteomyelitis model, beads coated with HA gel containing GM did not disturb bone ongrowth in the femoral stem. Our bioabsorbable carrier of antibiotic-containing HA gel is effective for prophylactic treatment or treatment of an actual deep infection following total joint arthroplasty.
Medical subject headings
- Anti-Bacterial Agents
- Arthroplasty, Replacement, Hip
- Coated Materials, Biocompatible
- Drug Carriers
- Gentamicins
- Hyaluronic Acid
- Staphylococcus aureus
Anatomy
- hip